Download Heart Disease - Oxford Medicine Online

THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE
Chapter 32 Sports and
Heart Disease
Domenico Corrado, Cristina Basso,
Antonio Pelliccia, and Gaetano Thiene
References
1 Fletcher GF, Balady G, Blair SN, et al. Statement on exercise:
benefits and recommendations for physical activity programs
for all Americans. A statement for health professionals by
the Committee on Exercise and Cardiac Rehabilitation of the
Council on Clinical Cardiology, American Heart Association.
Circulation 1996; 94: 857–62.
2 Thompson PD, Buchner D, Pina IL, et al. Exercise and physical
activity in the prevention and treatment of atherosclerotic
cardiovascular disease: a statement from the Council on
Clinical Cardiology (Subcommittee on Exercise, Rehabilitation,
and Prevention) and the Council on Nutrition, Physical
Activity, and Metabolism (Subcommittee on Physical Activity).
Circulation 2003; 107: 3109–16.
3 Curfman GD. The Health benefits of exercise. A critical
reappraisal. N Engl J Med 1993; 328: 574–6.
4 Maron BJ. The paradox of exercise. N Engl J Med 2000; 343:
1409–11.
5 Thompson PD, Funk EJ, Carleton RA, et al. Incidence of death
during jogging in Rhode Island from 1975 through 1980. JAMA
1982; 247: 2535–8.
6 Siscovick DS, Weiss NS, Fletcher RH, et al. The incidence of
primary cardiac arrest during vigorous exercise. N Engl J Med
1984; 311: 874–7.
7 Willich SN, Lewis M, Lowel H, et al. Physical exertion
as a trigger of acute myocardial infarction. Triggers and
Mechanisms of Myocardial Infarction Study Group. N Engl J
Med 1993; 329: 1684–90.
8 Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg
RJ, Muller JE. Triggering of acute myocardial infarction by
heavy physical exertion. Protection against triggering by regular
exertion. Determinants of Myocardial Infarction Onset Study
Investigators. N Engl J Med 1993; 329: 1677–83.
9 Corrado D, Basso C, Thiene G. Assay Sudden death in young
athletes. Lancet 2005; 366(Suppl.1): S47–S48.
10 Corrado D, Thiene G, Nava A, et al. Sudden death in young
competitive athletes: clinico-pathologic correlations in 22 cases.
Am J Med 1990; 89: 588–96.
11 Mitchell J, Haskell WL, Raven PB. Classification of Sports. J Am
Coll Cardiol 1994; 24: 864–66.
12 Huston TP, Puffer JC, Rodney WM. The athletic heart
syndrome. N Engl J Med. 1985; 313: 24–32.
13 Rost R. The athlete’s heart: historical perspective. In Maron BJ
(ed.) Cardiology Clinics, the Athlete’s Heart, 1992. Philadelphia,
PA: WB Saunders Co., pp. 197–207.
2nd edition
14 Morganroth J, Maron BJ, Henry WL, et al. Comparative left
ventricular dimensions in trained athletes. Ann Intern Med
1975; 82: 521–4.
15 Maron BJ, Pelliccia A. The heart of trained athletes: cardiac
remodeling and the risks of sports, including sudden death.
Circulation 2006; 114: 1633–44.
16 Pelliccia A, Maron BJ, Culasso F, et al. Clinical significance of
abnormal electrocardiographic patterns in trained athletes.
Circulation 2000; 102: 278–84.
17 Pelliccia A, Maron BJ, Spataro A, et al. The upper limit of
physiologic cardiac hypertrophy in highly trained elite athletes.
N Engl J Med 1991; 324: 295–301.
18 Pelliccia A, Culasso F, Di Paolo F, et al. Physiologic left
ventricular cavity dilatation in elite athletes. Ann Intern Med
1999; 130: 23–31.
19 Pelliccia A, Maron BJ, Culasso F, et al. Athlete’s heart in
women: echocardiographic characterization of highly trained
elite female athletes. JAMA 1996; 276: 211–15.
20 Douglas PS, O’Toole ML, Katz SE, et al. Left ventricular
hypertrophy in athletes. Am J Cardiol 1997; 80: 1384–8.
21 Abernethy WB, Choo JK, Hutter AM Jr. Echocardiographic
characteristics of professional football players. J Am Coll
Cardiol 2003; 41: 280–4.
22 Longhurst JC, Kelly AR, Gonyea WJ, et al. Chronic training
with static and dynamic exercise: cardiovascular adaptation, and
response to exercise. Circ Res 1981; 48(Suppl.I): I-172–I-178.
23 Pluim BM, Zwinderman AH, van der Laarse A, et al. The
athlete’s heart: a meta-analysis of cardiac structure and
function. Circulation 1999; 100: 336–44.
24 Scharhag J, Schneider G, Urhausen A, et al. Athlete’s heart:
right and left ventricular mass and function in male endurance
athletes and untrained individuals determined by magnetic
resonance imaging. J Am Coll Cardiol 2002; 410: 1856–63.
25 Milliken MC, Stray-Gundersen J, Peshock RM, et al. Left
ventricular mass as determined by magnetic resonance imaging
in male endurance athletes. Am J Cardiol 1988; 62: 301–5.
26 Magalski A, Maron BJ. Main ML, et al. Relation of race to
electrocardiographic patterns in elite American football players.
J Am Coll Cardiol 2008; 51: 2250–5.
27 Basavarajaiah S, Boraita A, Whyte G, et al. Ethnic differences in
left ventricular remodeling in highly-trained athletes: relevance
to differentiating physiologic left ventricular hypertrophy from
hypertrophic cardiomyopathy. J Am Coll Cardiol 2008; 51:
2256–62.
28 Montgomery HE, Clarkson P, Dollery CM, et al. Association of
angiotensin-converting enzyme gene I/D polymorphism with
change in left ventricular mass in response to physical training.
Circulation 1997; 96: 741–7.
29 Karjalainen J, Kujala HM, Stolt A, et al. Angiotensinogen gene
M235T polymorphism predicts left ventricular hypertrophy in
endurance athletes. J Am Coll Cardiol 1999; 34: 494: 9.
30 Corrado D, McKenna WJ. Appropriate interpretation of the
athlete‘s electrocardiogram saves lives as well as money. Eur
Heart J 2007; 28: 1920–2.
31 Corrado D, Maron BJ, Basso C, Pelliccia A, et al. Sudden cardiac
death in athletes. In Gussac I, Antzelevitch C (eds.) Electrical
diseases of the heart, 2008. London: Springer-Verlag, pp. 911–23.
© 2009 The European Society of Cardiology
Camm-Chap-32-Ref.indd 1
7/17/2009 3:35:01 PM
THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE
32 Maron, B.J. Sudden death in young athletes. N Engl J Med 2003;
349: 1064–75.
33 Thompson PD, Funk EJ, Carleton RA, et al. Incidence of death
during jogging in Rhode Island from 1975 through 1980. JAMA
1982; 247: 2535–8.
34 Van Camp SP, Bloor CM, Mueller FO, et al. Non-traumatic
sports death in high school and college athletes. Med Sci Sports
Exerc 1995; 27: 641–7.
35 Maron BJ, Gohman TE, Aeppli D. Prevalence of sudden cardiac
death during competitive sports activities in Minnesota high
school athletes. J Am Coll Cardiol 1998; 32: 1881–4.
36 Corrado D, Basso C, Rizzoli G, et al. Does sports activity
enhance the risk of sudden death in adolescents and young
adults? J Am Coll Cardiol 2003; 42: 1959–63.
37 Corrado D, Basso C, Poletti A, et al. Sudden death in the
young: is coronary thrombosis the major precipitating factor?
Circulation 1994; 90: 2315–23.
38 Thiene G, Nava A, Corrado D, et al. Right ventricular
cardiomyopathy and sudden death in young people. N Engl J
Med 1988; 318: 129–33.
39 Corrado D, Migliore F, Basso C, et al. Exercise and the risk of
sudden cardiac death. Herz 2006; 31: 553–8.
40 Waller BF, Roberts WC. Sudden death while running in
conditioned runners aged 40 years or over. Am J Cardiol 1980;
45: 1292–300.
41 Virmani R, Robinowitz M, McAllister HA. Non-traumatic
death in joggers. Am J Med 1982; 72: 874–81.
42 Thompson PD, Franklin BA, Balady GJ, et al. American Heart
Association Council on Nutrition, Physical Activity, and
Metabolism; American Heart Association Council on Clinical
Cardiology; American College of Sports Medicine. Exercise and
acute cardiovascular events placing the risks into perspective:
a scientific statement from the American Heart Association
Council on Nutrition, Physical Activity, and Metabolism and the
Council on Clinical Cardiology. Circulation 2007; 115: 2358–68.
43 Curfman GD. Is exercise beneficial- or hazardous- to your
heart? N Engl J Med 1993; 239: 1730–1.
44 Siscovick DS, Weiss NS, Fletcher RH, et al. The incidence of
primary cardiac arrest during vigorous exercise. N Engl J Med
1984; 311: 874–7.
45 Willich SN, Lewis M, Lowel H, et al. Physical exertion
as a trigger of acute myocardial infarction. Triggers and
Mechanisms of Myocardial Infarction Study Group. N Engl J
Med 1993; 329: 1684–90.
46 Mittleman MA, Maclure M, Tofler GH, et al. Triggering
of acute myocardial infarction by heavy physical exertion.
Protection against triggering by regular exertion. Determinants
of Myocardial Infarction Onset Study Investigators. N Engl J
Med 1993; 329: 1677–83.
47 Corrado D, Basso C, Schiavon M, et al. Screening for
hypertrophic cardiomyopathy in young athletes. N Engl J Med
1998; 339: 364–9.
48 Corrado D, Thiene G, Cocco P, et al. Non-atherosclerotic
coronary artery disease and sudden death in the young.
Br Heart J 1992; 68: 601–7.
49 Basso C, Frescura C, Corrado D, et al. Congenital heart disease
and sudden death in the young. Hum Path 1995; 26: 1065–72.
2nd edition
50 Corrado D, Basso C, Thiene G, et al. Spectrum of
clinicopathologic manifestations of arrhythmogenic right
ventricular cardiomyopathy/dysplasia: a multicenter study. J
Am Coll Cardiol 1997; 30: 1512–20.
51 Basso C, Maron BJ, Corrado D, et al. Clinical profile of
congenital coronary artery anomalies with origin from
the wrong aortic sinus leading to sudden death in young
competitive athletes. J Am Coll Cardiol 2000; 35: 1493–501.
52 Basso C, Thiene G, Corrado D, et al. Hypertrophic
cardiomyopathy: pathologic evidence of ischemic damage in
young sudden death victims. Hum Pathol 2000; 31: 988–98.
53 Basso C, Corrado D, Rossi L, Thiene G. Ventricular
preexcitation in children and young adults: atrial myocarditis
as a possible trigger of sudden death. Circulation 2001; 103:
269–75.
54 Corrado D, Basso C, Buja G, et al. Right bundle branch block,
right precordial ST-segment elevation, and sudden death in
young people. Circulation 2001; 103: 710–17.
55 Corrado D, Basso C, Thiene G. Sudden cardiac death in young
people with apparently normal heart. Cardiovasc Res 2001; 50:
399–408.
56 Burke AP, Farb A, Malcom GT, et al. Plaque rupture and
sudden death related to exertion in men with coronary artery
disease. JAMA 1999; 281: 921–6.
57 Giri S, Thompson PD, Kiernan FJ, et al. Clinical and
angiographic characteristics of exertion-related acute
myocardial infarction. JAMA 1999; 282: 1731–6.
58 Burke AP, Farb A, Virmani R, et al. Sports-related and nonsports-related sudden cardiac death in young adults. Am Heart
J 1991; 121: 568–75.
59 Corrado D, Thiene G, Pennelli N. Sudden death as the first
manifestation of coronary artery disease in young people (less
than or equal to 35 years). Eur Heart J 1988; 9: 139–44.
60 Maron BJ. Hypertrophic cardiomyopathy: A systematic review.
JAMA 2002; 237: 1308–20.
61 Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young
competitive athletes. Clinical, demographics,and pathological
profiles. JAMA 1996; 276: 199–204.
62 Nistri S, Thiene G, Basso C, et al. Screening for hypertrophic
cardiomyopathy in a young male military population. Am J
Cardiol 2003; 91: 1021–3.
63 Pelliccia A, Di Paolo FM, Corrado D, et al. Evidence for
efficacy of the Italian national pre-participation screening
programme for identification of hypertrophic cardiomyopathy
in competitive athletes. Eur Heart J 2006; 27: 2196–200.
64 Basso C, Thiene G, Corrado D, et al. Arrhythmogenic
right ventricular cardiomyopathy. Dysplasia, dystrophy, or
myocarditis? Circulation 1996; 94: 983–91.
65 Corrado D, Fontaine G, Marcus FI, et al. Arrhythmogenic
right ventricular dysplasia/cardiomyopathy: need for an
international registry. Circulation 2000: 21; 101: e101–e106.
66 Corrado D, Basso C, Thiene G. Arrhythmogenic right
ventricular cardiomyopathy: diagnosis, prognosis, and
treatment. Heart 2000; 83: 588–95.
67 Corrado D, Thiene G. Arrhythmogenic right ventricular
cardiomyopathy/dysplasia: clinical impact of molecular genetic
studies. Circulation 2006; 113: 1634–7.
© 2009 The European Society of Cardiology
Camm-Chap-32-Ref.indd 2
7/17/2009 3:35:01 PM
THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE
68 Corrado D, Basso C, Pavei A, et al. Trends in sudden
cardiovascular death in young competitive athletes after
implementation of a preparticipation screening program.
JAMA 2006; 296: 1593–601.
69 Basso C, Calabrese F, Corrado D, et al. Postmortem diagnosis
in sudden cardiac death victims: macroscopic, microscopic and
molecular findings. Cardiovasc Res 2001; 50: 290–300.
70 Kapetanopoulos A, Kluger J, Maron BJ, et al. The congenital
long QT syndrome and implications for young athletes. Med
Sci Sports Exerc 2006; 38: 816–25.
71 Wilde AA, Antzelevitch C, Borggrefe M, et al. Study Group on
the Molecular Basis of Arrhythmias of the European Society
of Cardiology. Proposed diagnostic criteria for the Brugada
syndrome: consensus report. Circulation 2002; 106: 2514–9.
72 Corrado D, Pelliccia A, Antzelevitch C, et al. ST-segment
elevation and sudden death in the athlete. In Antzelevitch
C, Brugada P (eds.) The Brugada Syndrome: From Bench to
Bedside, 2005. Oxford: Blackwell Publishing, pp. 119–129.
73 Priori SG, Napolitano C, Memmi M, et al. Clinical and
molecular characterization of patients with catecholaminergic
polymorphic ventricular tachycardia. Circulation 2002; 106:
69–74.
74 Maron BJ, Poliac LC, Ashare AB, et al. Sudden death due to
blunt neck blows in amateur hockey players. JAMA 2003; 290:
599–601.
75 Maron BJ, Gohman TE, Kyle SB, et al. Clinical profile and
spectrum of commotio cordis. JAMA 2002; 287: 1142–6.
76 Link MS, Wang PJ, Pandian NG, et al. An experimental
model of sudden death due to low-energy chest-wall impact
(commotio cordis). N Engl J Med 1998; 338: 1805–11.
77 Link MS, Wang PJ, VanderBrink BA, et al. Selective activation
of the K+ATP channel is a mechanism by which sudden death is
produced by low energy chest wall impact (commotio cordis).
Circulation 1999; 100: 413–18.
78 Maron BJ, Bodison SA, Wesley YE, et al. Results of screening
a large group of intercollegiate competitive athletes for
cardiovascular disease. J Am Coll Cardiol 1987; 10: 1214–21.
79 Maron BJ, Thompson PD, Ackerman MJ, et al.
Recommendations and considerations related to
preparticipation screening for cardiovascular abnormalities
in competitive athletes: 2007 update: a scientific statement
from the American Heart Association Council on Nutrition,
PhysicalActivity, and Metabolism: endorsed by the American
College of Cardiology Foundation. Circulation 2007; 115:
1643–455.
80 Grafe MW, Paul GR, Foster TE. The preparticipation sport
examination for high school and college athletes. Clin Sports
Med 1997; 16: 570–91.
81 Glover DW, Maron BJ. Profile of preparticipation cardiovascular
screening for high school athletes. JAMA 1998; 279: 1817–9.
82 Pfister GC, Puffer JC, Maron BJ. Preparticipation
cardiovascular screening for US collegiate student-athletes.
JAMA 2000; 283: 1597–9.
83 Decree of the Italian Ministry of Health, February 18: 1982.
Norme per la tutela sanitaria dell' sportiva agonistica (rules
concerning the medical protection of athletic activity). Gazzetta
Ufficiale: 1982: 63.
2nd edition
84 Pelliccia A, Maron BJ. Preparticipation cardiovascular
evaluation of the competitive athlete: perspectives from the
30-year Italian experience. Am J Cardiol 1995; 75: 827–9.
85 Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular
pre-participation screening of young competitive athletes for
prevention of sudden death: proposal for a common European
protocol. Consensus Statement of the Study Group of Sport
Cardiology of the Working Group of Cardiac Rehabilitation
and Exercise Physiology and the Working Group of Myocardial
and Pericardial Diseases of the European Society of Cardiology.
Eur Heart J 2005; 26: 516–24.
86 Corrado D, Basso C, Schiavon M, et al. Pre-participation
screening of young competitive athletes for prevention of
sudden cardiac death. J Am Coll Cardiol 2008; 52: 1981–9.
87 Maron BJ, Zipes DP. 36th Bethesda Conference:
recommendations for determining eligibility for competition
in athletes with cardiovascular abnormalities. J Am Coll Cardiol
2005; 45: 1373–5.
88 Pelliccia A, Fagard R, Bjornstad HH, et al. Recommendations
for competitive sports participation in athletes with
cardiovascular disease: a consensus document from the Study
Group of Sports Cardiology of the Working Group of Cardiac
Rehabilitation and Exercise Physiology and the Working Group
of Myocardial and Pericardial Diseases of the European Society
of Cardiology. Eur Heart J 2005; 26: 1422–45.
89 Maron BJ, Gardin JM, Flack JM, et al. Prevalence of
hypertrophic cardiomyopathy in a general population of young
adults: echocardiographic analysis of 4111 subjects in CARDIA
study. Circulation 1995; 92: 785–9.
90 Maron BJ, Chaitman BR, Ackerman MJ, et al.
Recommendations for physical activity and recreational sports
participation for young patients with genetic cardiovascular
diseases. Circulation 2004; 109: 2807–16.
91 Myerburg RJ, Vetter VL. Electrocardiograms should be
included in preparticipation screening of athletes. Circulation
2007; 116: 2616–26.
92 Fuller CM. Cost-effectiveness analysis of screening of high
school athletes for risk of sudden cardiac death. Med Sci Sports
Exerc 2000; 32: 887–90.
93 Tanaka Y, Yoshinaga M, Anan R, et al. and cost-effectiveness of
cardiovascular screening of young adolescents. Med Sci Sports
Exerc 2006; 38: 2–6.
94 Quaglini S, Rognoni C, Spazzolini C, et al. Cost-effectiveness of
neonatal ECG screening for the long QT sindrome. Eur Heart J
2006; 27: 1824–32.
95 Foote CB, Michaud GF. The Athlete’s electrocardiogram:
distinguishing normal from abnormal. In Estes NAM, Salem
DN, Wang PJ (eds.) Sudden Cardiac Death in the Athlete, 1998.
Armonk, NY; Futura Publishing, pp.101–13.
96 Wu J, Stork TL, Perron AD, et al. The athlete’s
electrocardiogram. Am J Emerg Med 2006; 24: 77–86.
97 Pelliccia A, Culasso F, Di Paolo F, et al. Prevalence of abnormal
electrocardiograms in a large, unselected athlete population
undergoing preparticipation cardiovascular screening. Eur
Heart J 2007; 28: 2006–10.
98 Somauroo JD, Pyatt JR, Jackson M, et al. An echocardiographic
assessment of cardiac morphology and common ECG findings
© 2009 The European Society of Cardiology
Camm-Chap-32-Ref.indd 3
7/17/2009 3:35:01 PM
THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE
in teenage professional soccer players: reference ranges for use
in screening. Heart 2001; 85: 649–54.
99 Ryan MP, Cleland JGF, French JA, et al. The standard
electrocardiogram as a screening test for hypertrophic
cardiomyopathy. Am J Cardiol 1995; 76: 689–94.
100 Melacini P, Fasoli G, Canciani B, et al. Hypertrophic
cardiomyopathy: Two-dimensional echocardiografic score
versus clinical and electrocardiographic findings. Clin Cardiol
1989; 12: 443–52.
101 Sharma S, Whyte G, Elliott P, et al. Electrocardiographic
changes in 1000 highly trained junior elite athletes. Br J Sports
Med 1999; 33: 319–324.
102 Douglas PS, O' ML, Hiller WDB, et al. Electrocardiographic
diagnosis of exercise-induced left ventricular hypertrophy. Am
Heart J 1988; 116: 784–90.
103 Marcus FI. Prevalence of T-wave inversion beyond V1 in
young normal individuals and usefulness for the diagnosis of
arrhythmogenic right ventricular cardiomyopathy/ dysplasia.
Am J Cardiol 2005; 95: 1070–1.
104 McKenna WJ, Spirito P, Desnos M, et al. Experience from
clinical genetics in hypertrophic cardiomyopathy: proposal for
new diagnostic criteria in adult members of affected families.
Heart 1997; 77: 130–2.
105 Pelliccia A, Di Paolo FM, Quattrini FM, et al. Outcomes in
athletes with marked ECG repolarization abnormalities. N
Engl J Med 2008; 10; 358: 152–61.
106 Mitchell JE, Maron BJ, Epstein SE. 16th Bethesda Conference:
cardiovascular abnormalities in the athlete: recommendations
regarding eligibility for competition. J Am Coll Cardiol 1985;
6: 1186–232.
107 Maron BJ, Mitchell JH. 26th Bethesda Conference:
recommendations for detecting eligibility for competition in
athletes with cardiovascular abnormalities. J Am Coll Cardiol
1994; 24: 845–99.
108 Lewis JF, Spirito P, Pelliccia A, et al. Usefulness of
Doppler echocardiographic assessment of diastolic filling
in distinguishing “athlete’s heart” from hypertrophic
cardiomyopathy. Am J Cardiol 1992; 68: 296–300.
109 Maron BJ, Pelliccia A, Spataro A, et al. Reduction in left
ventricular wall thickness after deconditioning in highly
trained Olympic athletes. Br Heart J 1993; 69: 125–8.
110 Sharma S, Elliott PM, Whyte G, et al. Utility of
metabolic exercise testing in distinguishing hypertrophic
cardiomyopathy from physiologic left ventricular hypertrophy
in athletes. J Am Coll Cardiol 2000; 36: 864–70.
111 Maron BJ, Moller JH, Seidman CE, et al. Impact of laboratory
molecular diagnosis on contemporary diagnostic criteria for
genetically transmitted cardiovascular diseases: Hypertrophic
cardiomyopathy, long-QT syndrome, and Marfan syndrome.
Circulation 1998; 98: 1460–71.
112 McKenna WJ, Thiene G, Nava A, et al. Diagnosis of
arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Br Heart J 1994; 71: 215–18.
113 Turrini P, Corrado D, Basso C, et al. Dispersion of ventricular
depolarization-repolarization: a noninvasive marker for
risk stratification in arrhythmogenic right ventricular
cardiomyopathy. Circulation 2001; 103: 3075–80.
2nd edition
114 Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive
detection of myocardial fibrosis in arrhythmogenic right
ventricular cardiomyopathy using delayed-enhancement
magnetic resonance imaging. J Am Coll Cardiol 2005; 45:
98–103.
115 Sen-Chowdhry S, Prasad SK, Syrris P, et al. Cardiovascular
magnetic resonance in arrhythmogenic right ventricular
cardiomyopathy revisited: comparison with task force criteria
and genotype. J Am Coll Cardiol 2006; 48: 2132–40.
116 Morgera T, Dilenarda A, Dreas L, et al. Electrocardiography of
myocarditis revisited: Clinical and prognostic significance of
electrocardiographic changes. Am Heart J 1992; 124: 455–66.
117 Pianamonti B, Albed E, Cigalotto A, et al. Echocardiographic
findings in myocarditis. Am J Cardiol 1988; 62: 2285–91.
118 Timmermans C, Smeets JL, Rodriguez LM, et al. Aborted
sudden death in the Wolff–Parkinson–White syndrome. Am J
Cardiol 1995; 76: 492–4.
119 Pappone C, Santinelli V, Rosanio S, et al. Usefulness of invasive
electrophysiologic testing to stratify the risk of arrhythmic
events in asymptomatic patients with Wolff–Parkinson–White
pattern: results from a large prospective long-term follow-up
study. J Am Coll Cardiol 2003; 41: 239–44.
120 Mont L, Sambola A, Brugada J, et al. Long-lasting sport
practice and lone atrial fibrillation. Eur Heart J 2002; 23:
477–82.
121 Karjalainen J, Kujala UM, Kaprio J, et al. Lone atrial
fibrillation in vigorously exercising middle aged men:
case–control study. BMJ 1998; 316: 1784–5.
122 Heidbuchel H, Anne W,Willems R, et al. Endurance sports is a
risk factor for atrial fibrillation after ablation for atrial flutter.
Int J Cardiol 2005; 107: 67–72.
123 Mont L, Elosua R, Brugada J. Endurance sport practice as a
risk factor for atrial fibrillation and atrial flutter. Europace
2009; 11: 11–17.
124 Pelliccia A, Maron BJ, Di Paolo FM, et al. Prevalence and
clinical significance of left atrial remodeling in competitive
athletes. J Am Coll Cardiol 2005; 46: 690–6.
125 Sullivan ML, Martinez CM, Gallagher EJ. Atrial fibrillation
and anabolic steroids. J Emerg Med 1999; 17: 851–7.
126 Levy S, Camm AJ, Saksena S, et al. International consensus
on nomenclature and classification of atrial fibrillation; a
collaborative project of the Working Group on Arrhythmias
and the Working Group on Cardiac Pacing of the European
Society of Cardiology and the North American Society of
Pacing and Electrophysiology. Europace 2003; 5: 119–22.
127 Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation
of atrial fibrillation by ectopic beats originating in the
pulmonary veins. N Engl J Med 1998; 339: 659–66.
128 Pappone C, Oreto G, Rosanio S, et al. Atrial electroanatomic
remodeling after circumferential radiofrequency pulmonary
vein ablation: efficacy of an anatomic approach in a large
cohort of patients with atrial fibrillation. Circulation 2001;
104: 2539–44.
129 Reynolds MW, Fahrbach K, Hauch O, et al. Warfarin
anticoagulation and outcomes in patients with atrial
fibrillation: a systematic review and metaanalysis. Chest 2004;
126:1938–45.
© 2009 The European Society of Cardiology
Camm-Chap-32-Ref.indd 4
7/17/2009 3:35:01 PM
THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE
130 Biffi A, Pelliccia A, Verdile L et al. Long-term clinical
significance of frequent and complex ventricular
tachyarrhythmias in trained athletes. J Am Coll Cardiol 2002;
40: 446–52.
131 Mosvowitz C, Schwartzman D, Callans DJ, et al. Idiopathic
right ventricular outflow tract tachycardia: narrowing the
anatomical location for successful ablation. Am Heart J 1996;
131: 930–6.
132 Corrado D, Basso C, Leoni L, et al. Three-dimensional
electroanatomical voltage mapping and histologic evaluation
of myocardial substrate in right ventricular outflow tract
tachycardia. J Am Coll Cardiol 2008; 51: 731–9.
133 Lin F, Finley D, Rahmtoola J, Wu D. Idiopathic
paroxysmal ventricular tachycardia with a QRS pattern
of right bundle branch block and left axis deviation: a
unique clinical entity with specific properties. Am J Cardiol
1983; 52: 95.
134 Sen-Chowdhry S, Syrris P, Prasad SK, et al. Left-dominant
arrhythmogenic cardiomyopathy: an under-recognized
clinical entity. J Am Coll Cardiol 2008; 52: 2175–87.
135 Priori SG, Barhanin J, Hauer RNW, et al. Genetic and
molecular basis of cardiac arrhythmias. Impact on clinical
management. Eur Heart J 1999; 20: 174–95.
136 Cregler LL. Substance abuse in sports: The impact of cocaine,
alcohol, steroids, and other drugs on the heart. In Williams
RA (ed.) The Athlete and Heart disease, 1999. Philadelphia, PA:
Lippincott, Williams and Wilkins, pp. 131–53.
137 Maron BJ, Araujo CGS, Thompson PD, et al. AHA Science
Advisory: Recommendations for preparticipation screening
and the assessment of cardiovascular disease in masters
athletes. Circulation 2001; 103: 327–34.
138 DeBacker G, Ambrosioni E, Borch-Johnsen K, et al. European
guidelines on cardiovascular disease prevention in clinical
practice. Third Joint Task Force of European and Other
Societies on Cardiovascular Disease Prevention in Clinical
Practice. Eur Heart J 2003; 24: 1601–10.
2nd edition
139 Memisoglu E, Ropers D, Hobikoglu G, et al. Usefulness
of electron beam computed tomography fro diagnosis of
anomalous origin of a coronary artery from the opposite
sinus. Am J Cardiol 2005; 96: 1452–5.
140 McConnel MV, Ganz P, Selwiyn AP, et al. Identification of
anomalous coronary arteries and their anatomic course by
magnetic resonance coronary angiography. Circulation 1995;
92: 3158–62.
141 Heidbüchel H. Implantable cardioverter defibrillator therapy
in athletes. Cardiol Clin 2007; 25: 467–82.
142 Drezner JA, Rogers KJ. Sudden cardiac arrest in intercollegiate
athletes: Detailed analysis and outcomes of resuscitation in
nine cases. Heart Rhythm 2006; 3: 755–9.
143 Maron BJ, Wentzel DC, Zenovich AG, et al. Death in a young
athlete due to commotio cordis despite prompt external
defibrillation. Heart Rhythm 2005; 2: 991–3.
144 Oswald D, Dvorak J, Corrado D, et al. Sudden cardiovascular
death in sport. Lausanne recommendations: preparticipation
cardiovascular screening. Available at: http: //www.olympic.
org/uk/news/olympic_news/full_story_uk.asp?id_1182.
145 Maron BJ, Towbin JA, Thiene G, et al. American Heart
Association; Council on Clinical Cardiology, Heart Failure and
Transplantation Committee; Quality of Care and Outcomes
Research and Functional Genomics and Translational Biology
Interdisciplinary Working Groups; Council on Epidemiology
and Prevention. Contemporary definitions and classification
of the cardiomyopathies: an American Heart Association
Scientific Statement from the Council on Clinical Cardiology,
Heart Failure and Transplantation Committee; Quality of
Care and Outcomes Research and Functional Genomics and
Translational Biology Interdisciplinary Working Groups; and
Council on Epidemiology and Prevention. Circulation 2006
11; 113: 1807–16.
146 Thiene G, Corrado D, Basso C. Revisiting definition and
classification of cardiomyopathies in the era of molecular
medicine. Eur Heart J 2008; 29: 144–6.
© 2009 The European Society of Cardiology
Camm-Chap-32-Ref.indd 5
7/17/2009 3:35:01 PM